Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Springer

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|December 1, 1990
Disposition of the prodrug 4-(bis (2-chloroethyl) amino) benzoyl-L-glutamic acid and its active parent drug in miceP Antoniw, C J Springer, K D Bagshawe, et al.
Cancer|February 1, 1994
Galactosylated antibodies and antibody-enzyme conjugates in antibody-directed enzyme prodrug therapyS K Sharma, K D Bagshawe, P J Burke, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E. coli nitroreductase geneP F Searle, S J Weedon, I A McNeish, et al.
Disease Markers|May 1, 1991
Antibody directed enzyme prodrug therapy (ADEPT): clinical reportK D Bagshawe, S K Sharma, C J Springer, et al.
Disease Markers|May 1, 1991
Antibody directed enzyme prodrug therapy (ADEPT): a three phase systemS K Sharma, K D Bagshawe, C J Springer, et al.
Cell Biophysics|January 1, 1993
Antitumor effects of an antibody-carboxypeptidase G2 conjugate in combination with a benzoic acid mustard prodrugD C Blakey, B E Valcaccia, S East, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinomaM P Napier, S K Sharma, C J Springer, et al.
British Journal of Cancer|May 29, 2003
A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugsR A Spooner, F Friedlos, K Maycroft, et al.
British Journal of Cancer|November 1, 1995
Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugsD C Blakey, D H Davies, R I Dowell, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compoundsC J Springer, K D Bagshawe, S K Sharma, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|December 1, 1990
Disposition of the prodrug 4-(bis (2-chloroethyl) amino) benzoyl-L-glutamic acid and its active parent drug in miceP Antoniw, C J Springer, K D Bagshawe, et al.
Cancer|February 1, 1994
Galactosylated antibodies and antibody-enzyme conjugates in antibody-directed enzyme prodrug therapyS K Sharma, K D Bagshawe, P J Burke, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Sensitisation of human ovarian cancer cells to killing by the prodrug CB1954 following retroviral or adenoviral transfer of the E. coli nitroreductase geneP F Searle, S J Weedon, I A McNeish, et al.
Disease Markers|May 1, 1991
Antibody directed enzyme prodrug therapy (ADEPT): clinical reportK D Bagshawe, S K Sharma, C J Springer, et al.
Disease Markers|May 1, 1991
Antibody directed enzyme prodrug therapy (ADEPT): a three phase systemS K Sharma, K D Bagshawe, C J Springer, et al.
Cell Biophysics|January 1, 1993
Antitumor effects of an antibody-carboxypeptidase G2 conjugate in combination with a benzoic acid mustard prodrugD C Blakey, B E Valcaccia, S East, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinomaM P Napier, S K Sharma, C J Springer, et al.
British Journal of Cancer|May 29, 2003
A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugsR A Spooner, F Friedlos, K Maycroft, et al.
British Journal of Cancer|November 1, 1995
Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugsD C Blakey, D H Davies, R I Dowell, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compoundsC J Springer, K D Bagshawe, S K Sharma, et al.
Pageof 7